SCHEMBL22639206

SCHEMBL22639206

S=P(c1ccccc1)(c1ccccc1)c1ccc(-c2ccc(-c3ccc(-c4nc(-c5ccccc5)nc(-c5ccc(-c6ccccc6)cc5)n4)cc3)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 1/20 0.48
▸ ESR2 Q92731 1/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.48
▸ MEN1 O00255 6/20 0.46
▸ KMT2A Q03164 6/20 0.46
▸ ALDH1A1 P00352 4/20 0.46
▸ MAPT P10636 4/20 0.46
▸ HPGD P15428 3/20 0.46
▸ ADORA2A P29274 2/20 0.43
▸ ADORA1 P30542 2/20 0.43
▸ POLB P06746 1/20 0.43
▸ ADORA3 P0DMS8 1/20 0.43
▸ ADORA2B P29275 1/20 0.43
▸ NTSR1 P30989 1/20 0.41
▸ NPC1 O15118 6/20 0.41
▸ RAB9A P51151 6/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ SMN1; SMN2 Q16637 4/20 0.40
▸ NFKB1 P19838 3/20 0.40
▸ NFKB2 Q00653 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22639227 1.00 ESR1 (0.48) ESR1ESR2L3MBTL1MEN1KMT2A
SCHEMBL17403785 0.98 ESR1 (0.50) ESR1ESR2L3MBTL1MEN1KMT2A
SCHEMBL17403779 0.86 MEN1 (0.59) ESR1ESR2L3MBTL1MEN1KMT2A
SCHEMBL4780784 0.84 ESR1 (0.64) ESR1ESR2L3MBTL1ALDH1A1MAPK1
SCHEMBL17403794 0.83 ALDH1A1 (0.46) ESR1ESR2L3MBTL1MEN1KMT2A
SCHEMBL22639203 0.83 L3MBTL1 (0.48) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL22639201 0.83 L3MBTL1 (0.48) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL21122450 0.83 L3MBTL1 (0.48) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL22639200 0.83 L3MBTL1 (0.48) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL22639306 0.83 L3MBTL1 (0.48) L3MBTL1MEN1KMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10833277-B2 Heterocyclic compound and organic light emitting diode comprising same LG CHEM, LTD. (KR) 2020-11-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10833277-B2 Heterocyclic compound and organic light emitting diode comprising same CRY1, CRY2, DDT ESR1 25/4885ESR2 487/4885L3MBTL1 579/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback